The high school party days never really ended for a surprising number of middle-aged adults.
Novo Nordisk is feeling the competition from compounded GLP-1s, exec says
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS